SPRING NEIHART: Open Payments
NPI 1548999857 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 23 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $193 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $348 |
| Otsuka America Pharmaceutical, Inc. | 2 | $95 |
| E.R. Squibb & Sons, L.L.C. | 1 | $84 |
| Teva Pharmaceuticals USA, Inc. | 2 | $78 |
| Alkermes, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, COBENFY, ABILIFY MAINTENA, UZEDY, REXULTI, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across ID — which companies pay providers there.
